Abstract:Background: Continuous understanding of the epidemiology and evolution of multidrug resistant TB (MDR-TB) is key to develop the appropriate strategies for preventing its epidemic. The present study aimed to investigate the longitudinal trend of its rates, transmissions and transition to extensively drug resistant TB(XDR-TB), in an attempt to adjust the TB control activities in eastern rural China. Methods: The data presented here span 8 years (2003-2010) and consisted of three population-based investigation of drug resistant TB in terms of socio-demographic and clinical characteristics of drug resistant TB cases as well as the microbiological and molecular features of their infected Mtb strains, respectively in one 19 years’ DOTS covered eastern rural county: Deqing (DQ) and the other 9 years’ DOTS covered Guanyun (GY). Results: Within 9 years’ study, 901 TB patients were identified at local TB dispensaries in two counties, with 254 resistant to at least one of 1st line drugs. Of the 135 MDR-TB isolates, 6 were XDR-TB. Rate of drug resistant TB remained stable, even reduced in some period both in two counties, while the rate of MDR-TB and MDR-TB plus resistance to fluoroquinolones increased significantly respectively from 14.5% and 5.1% in 2003/2004 to 21.3% and 9.7% in 2009/2010. The IS6110 RFLP genotyping revealed the 21 clusters involving 48(28.4%) drug resistant TB cases in DQ and 28 clusters involving 59(32.1%) drug resistant TB cases in GY. The clustering proportion increased among the drug resistant TB cases especially for MDR-TB over the study period, reaching 52%(DQ) and 48%(GY) in 2010. And 2 XDR-TB isolates was identified within only 2 clusters 0f drug resistant Mtb in DQ. Designated as subtypes of Beijing family, totally 3 clusters (11 drug resistant TB cases) typical with katG315Thr mutation, persisted throughout the study period in two counties. Conclusion: A high increased recent transmission of MDR-TB might implicate it necessary to improve the effectiveness on diagnosis and treatment of MDR-TB. Despite an increasing trend of MDR plus the resistant to fluoroquinolones, the low proportion of XDR-TB among MDR-TB might indicate it neccessary to cautiously introduce some of 2 line drugs in MDR-TB treatment in China.

Prevalence, drug resistance, and genotypic diversity of the RDRio subfamily of Mycobacterium tuberculosis in Ecuador: a retrospective analysis for years 2012–2016

Molecular epidemiology of Mycobacterium tuberculosis in Ecuador: Recent advances and future challenges

Population structure of Mycobacterium tuberculosis in El Oro: a first insight into Ecuador-Peru tuberculosis transmission.

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

A first insight into tuberculosis transmission at the border of Ecuador and Colombia: a retrospective study of the population structure of Mycobacterium tuberculosis in Esmeraldas province

Tuberculosis multirresistente en Colombia, 2013-2018: estudio de casos y controles

Strengthening Multidrug-Resistant Tuberculosis Epidemiological Surveillance in Rio de Janeiro: a multidimensional analysis

Reduced Maxwell-Duffing description of extremely short pulses in nonresonant media.

Genetic diversity and drug susceptibility of Mycobacterium tuberculosis in a city with a high prevalence of drug resistant tuberculosis from Southeast of Mexico

Pan-genome association study of Mycobacterium tuberculosis lineage-4 revealed specific genes related to the high and low prevalence of the disease in patients from the North-Eastern area of Medellín, Colombia

Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro*

Genetic Characterization and Population Structure of Drug-Resistant Mycobacterium tuberculosis Isolated from Brazilian Patients Using Whole-Genome Sequencing

Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru

The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone

Genetic Diversity of Mycobacterium tuberculosis Strains Isolated from HIV-Infected Patients in Mexico

Population-based Molecular Epidemiologic Study of Rifampicin-Resistant Tuberculosis in Rural Area of Eastern China

Drug Resistance-Related Mutations in Multidrug-Resistant Mycobacterium Tuberculosis Isolates from Diverse Geographical Regions.

Surveillance for TB drug resistance using routine rapid diagnostic testing data: Methodological development and application in Brazil

Whole-genome sequencing-based genetic diversity, transmission dynamics, and drug-resistant mutations in Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia

Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China